Treatment of epithelial ovarian cancer with <em>HE4</em>-targeted antisense phosphorothioligos (PTOs)

Lokich, Elizabeth

260 - Poster Session A
Treatment of epithelial ovarian cancer with HE4-targeted antisense phosphorothioligos (PTOs)

Saturday, March 22, 2014: 2:05 AM

West Exhibit Hall (Tampa Convention Center)

E. Lokich¹, E. K. Hill¹, A. Han², N. Romano¹, T. Horan¹, N. Yano², K. Kim², R. Singh² and R. G. Moore¹
¹Women & Infants' Hospital, Brown University, Providence, RI, ²Women and Infants Hospital, Brown University, Providence, RI

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

260 - Poster Session A
Treatment of epithelial ovarian cancer with HE4-targeted antisense phosphorothioligos (PTOs)

260 - Poster Session A Treatment of epithelial ovarian cancer with HE4-targeted antisense phosphorothioligos (PTOs)

260 - Poster Session A
Treatment of epithelial ovarian cancer with HE4-targeted antisense phosphorothioligos (PTOs)